Investor Relations | STADA
Hemofarm - News - STADA Health Report: 81 percent of Europeans are open towards genetic testing
Annual Report 2022 | STADA
STADA's excellent results in H1 2023 | STADA
Investor Relations | STADA
Financial Reports - Investor Relations | STADA
IR Contact - Investor Relations | STADA
Press release: STADA ranks among top 10% of pharma firms on sustainability | Presseportal
News - Investor Relations | STADA
Annual Report 2022 | STADA
Investor Relations | STADA
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Investor Relations | STADA
Nidda Healthcare GmbH - Investor Relations
Financial Reports - Investor Relations | STADA
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
Investor Relations | STADA
Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is Improving
News - Investor Relations | STADA
Hemofarm - News - STADA's 2021 above-market development strengthens base for further growth, especially in Consumer Healthcare and Specialty
Investor Relations | STADA
Press release : STADA further grows its European Consumer Healthcare portfolio by ... | Presseportal
Financial Reports - Investor Relations | STADA
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Investor Relations | STADA
Press release: Zuellig Pharma becomes STADA Philippines' exclusive distribution partner | Presseportal
STADA diventa uno dei principali player del settore farmaceutico
